{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T05:02:54Z","timestamp":1779685374401,"version":"3.53.1"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-05918-5","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T02:59:04Z","timestamp":1779677944000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neurosteroid-Mediated Neuroprotection via mTORC1\/AMPK\/BDNF Signaling Pathway in Alzheimer\u2019s Disease"],"prefix":"10.1007","volume":"63","author":[{"given":"Moteb","family":"Khobrani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3097-2962","authenticated-orcid":false,"given":"Hayder M.","family":"Al-kuraishy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawar Raad","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9909-6318","authenticated-orcid":false,"given":"Aya M.","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaber El-Saber","family":"Batiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"issue":"4","key":"5918_CR1","first-page":"1","volume":"6","author":"PD Saragea","year":"2024","unstructured":"Saragea PD (2024) Alzheimer\u2019s disease (AD): environmental modifiable risk factors. International Journal for Multidisciplinary Research 6(4):1\u20131","journal-title":"Int J Multidiscip Res"},{"issue":"5","key":"5918_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0322574","volume":"20","author":"S Liu","year":"2025","unstructured":"Liu S, Geng D (2025) A systematic analysis for disease burden, risk factors, and trend projection of Alzheimer\u2019s disease and other dementias in China and globally. PLoS One 20(5):e0322574","journal-title":"PLoS One"},{"issue":"6","key":"5918_CR3","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1136\/jnnp-2023-332661","volume":"95","author":"V Patel","year":"2024","unstructured":"Patel V, Edison P (2024) Cardiometabolic risk factors and neurodegeneration: a review of the mechanisms underlying diabetes, obesity and hypertension in Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 95(6):581\u2013589","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"5918_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14218","volume":"21","author":"DB Hammers","year":"2025","unstructured":"Hammers DB et al (2025) Differences in baseline cognitive performance between participants with early-onset and late-onset Alzheimer\u2019s disease: comparison of LEADS and ADNI. Alzheimers Dement 21(1):e14218","journal-title":"Alzheimers Dement"},{"key":"5918_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/diseases12060110","author":"CA Valdez-Gaxiola","year":"2024","unstructured":"Valdez-Gaxiola CA et al (2024) Early- and late-onset Alzheimer\u2019s disease: two sides of the same coin? Diseases. https:\/\/doi.org\/10.3390\/diseases12060110","journal-title":"Diseases"},{"issue":"1","key":"5918_CR6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13024-025-00819-y","volume":"20","author":"DR Thal","year":"2025","unstructured":"Thal DR et al (2025) Alzheimer\u2019s disease neuropathology and its estimation with fluid and imaging biomarkers. Mol Neurodegener 20(1):33","journal-title":"Mol Neurodegener"},{"issue":"6","key":"5918_CR7","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.240035","volume":"14","author":"M Gyimesi","year":"2024","unstructured":"Gyimesi M, Okolicsanyi RK, Haupt LM (2024) Beyond amyloid and tau: rethinking Alzheimer\u2019s disease through less explored avenues. Open Biol 14(6):240035","journal-title":"Open Biol"},{"issue":"1","key":"5918_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s12017-025-08832-6","volume":"27","author":"EA Alzarea","year":"2025","unstructured":"Alzarea EA et al (2025) The conceivable role of metabolic syndrome in the pathogenesis of Alzheimer\u2019s disease: cellular and subcellular alterations in underpinning a tale of two. Neuromol Med 27(1):35","journal-title":"Neuromol Med"},{"issue":"11","key":"5918_CR9","doi-asserted-by":"publisher","first-page":"7859","DOI":"10.1002\/alz.14253","volume":"20","author":"RJ Perrin","year":"2024","unstructured":"Perrin RJ et al (2024) The Alzheimer\u2019s disease neuroimaging initiative neuropathology core: an update. Alzheimers Dement 20(11):7859\u20137870","journal-title":"Alzheimers Dement"},{"issue":"10","key":"5918_CR10","doi-asserted-by":"publisher","first-page":"3558","DOI":"10.1093\/brain\/awac202","volume":"145","author":"X Li","year":"2022","unstructured":"Li X et al (2022) Seeding, maturation and propagation of amyloid \u03b2-peptide aggregates in Alzheimer\u2019s disease. Brain 145(10):3558\u20133570","journal-title":"Brain"},{"issue":"10","key":"5918_CR11","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1007\/s00702-021-02371-7","volume":"128","author":"K Danics","year":"2021","unstructured":"Danics K et al (2021) Neurodegenerative proteinopathies associated with neuroinfections. J Neural Transm (Vienna) 128(10):1551\u20131566","journal-title":"J Neural Transm (Vienna)"},{"issue":"1","key":"5918_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13024-021-00476-x","volume":"16","author":"DC Chung","year":"2021","unstructured":"Chung DC et al (2021) Cellular and pathological heterogeneity of primary tauopathies. Mol Neurodegener 16(1):57","journal-title":"Mol Neurodegener"},{"key":"5918_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2025.177830","volume":"1002","author":"SM Alshahrani","year":"2025","unstructured":"Alshahrani SM et al (2025) LRP1 at the crossroads of Parkinson\u2019s and Alzheimer\u2019s: divergent roles in \u03b1-synuclein and amyloid pathology. Eur J Pharmacol 1002:177830","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"5918_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpet.2025.103639","volume":"392","author":"NH Almohmadi","year":"2025","unstructured":"Almohmadi NH et al (2025) Alzheimer disease: amyloid peptide controversies and challenges of anti-A\u03b2 immunotherapy. J Pharmacol Exp Ther 392(8):103639","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"5918_CR15","first-page":"43","volume":"15","author":"M Nasb","year":"2024","unstructured":"Nasb M, Tao W, Chen N (2024) Alzheimer\u2019s disease puzzle: delving into pathogenesis hypotheses. Aging Dis 15(1):43","journal-title":"Aging Dis"},{"issue":"6","key":"5918_CR16","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.3390\/molecules27061816","volume":"27","author":"Z-R Chen","year":"2022","unstructured":"Chen Z-R et al (2022) Role of cholinergic signaling in Alzheimer\u2019s disease. Molecules 27(6):1816","journal-title":"Molecules"},{"issue":"4","key":"5918_CR17","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1177\/10738584211069897","volume":"29","author":"PD Pinky","year":"2023","unstructured":"Pinky PD et al (2023) Recent insights on glutamatergic dysfunction in Alzheimer\u2019s disease and therapeutic implications. Neuroscientist 29(4):461\u2013471","journal-title":"Neuroscientist"},{"issue":"3","key":"5918_CR18","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/ibra.12098","volume":"9","author":"BC Tang","year":"2023","unstructured":"Tang BC, Wang YT, Ren J (2023) Basic information about memantine and its treatment of Alzheimer\u2019s disease and other clinical applications. Ibrain 9(3):340\u2013348","journal-title":"Ibrain"},{"issue":"3","key":"5918_CR19","doi-asserted-by":"publisher","first-page":"179","DOI":"10.2174\/0115672050381553250425062803","volume":"22","author":"DV Zaretsky","year":"2025","unstructured":"Zaretsky DV, Zaretskaia MV (2025) The framework for an integrative theory of Alzheimer\u2019s disease. Curr Alzheimer Res 22(3):179\u2013204","journal-title":"Curr Alzheimer Res"},{"issue":"2","key":"5918_CR20","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","volume":"179","author":"JM Long","year":"2019","unstructured":"Long JM, Holtzman DM (2019) Alzheimer disease: an update on pathobiology and treatment strategies. Cell 179(2):312\u2013339","journal-title":"Cell"},{"key":"5918_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21134812","author":"Y Akwa","year":"2020","unstructured":"Akwa Y (2020) Steroids and Alzheimer\u2019s disease: changes associated with pathology and therapeutic potential. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21134812","journal-title":"Int J Mol Sci"},{"key":"5918_CR22","unstructured":"Waheeb TS et al (n.d.)\u00a0Neurosteroids-mediated neuroprotection via mTORC1\/AMPK\/BDNF signaling pathway in Alzheimer\u2019s disease. BDNF Signaling Pathway in Alzheimer's disease"},{"issue":"2","key":"5918_CR23","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00213-013-3276-5","volume":"230","author":"CM Carver","year":"2013","unstructured":"Carver CM, Reddy DS (2013) Neurosteroid interactions with synaptic and extrasynaptic GABA(A) receptors: regulation of subunit plasticity, phasic and tonic inhibition, and neuronal network excitability. Psychopharmacology 230(2):151\u2013188","journal-title":"Psychopharmacology"},{"issue":"2","key":"5918_CR24","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13028","volume":"34","author":"DS Reddy","year":"2022","unstructured":"Reddy DS (2022) Neurosteroid replacement therapy for catamenial epilepsy, postpartum depression and neuroendocrine disorders in women. J Neuroendocrinol 34(2):e13028","journal-title":"J Neuroendocrinol"},{"issue":"1","key":"5918_CR25","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41386-023-01626-z","volume":"49","author":"JL Maguire","year":"2024","unstructured":"Maguire JL, Mennerick S (2024) Neurosteroids: mechanistic considerations and clinical prospects. Neuropsychopharmacology 49(1):73\u201382","journal-title":"Neuropsychopharmacology"},{"issue":"1\u20102","key":"5918_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0248-4900(91)90045-O","volume":"71","author":"\u00c9\u00c9 Baulieu","year":"1991","unstructured":"Baulieu \u00c9\u00c9 (1991) Neurosteroids: a new function in the brain. Biology of the Cell 71(1\u20102):3\u201310","journal-title":"Biol Cell"},{"key":"5918_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/life14050582","author":"I Balan","year":"2024","unstructured":"Balan I et al (2024) Neuroactive steroids, Toll-like receptors, and neuroimmune regulation: insights into their impact on neuropsychiatric disorders. Life. https:\/\/doi.org\/10.3390\/life14050582","journal-title":"Life"},{"issue":"6","key":"5918_CR28","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1096\/fasebj.6.6.1347506","volume":"6","author":"SM Paul","year":"1992","unstructured":"Paul SM, Purdy RH (1992) Neuroactive steroids. FASEB J 6(6):2311\u20132322","journal-title":"Faseb J"},{"key":"5918_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/biom11040553","author":"M Kaleta","year":"2021","unstructured":"Kaleta M et al (2021) Analytical methods for the determination of neuroactive steroids. Biomolecules. https:\/\/doi.org\/10.3390\/biom11040553","journal-title":"Biomolecules"},{"issue":"12 Pt A","key":"5918_CR30","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1016\/j.bbadis.2014.09.013","volume":"1842","author":"A Grimm","year":"2014","unstructured":"Grimm A et al (2014) Improvement of neuronal bioenergetics by neurosteroids: implications for age-related neurodegenerative disorders. Biochim Biophys Acta 1842(12 Pt A):2427\u201338","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"5918_CR31","doi-asserted-by":"publisher","DOI":"10.1111\/jne.13045","volume":"34","author":"D Belelli","year":"2022","unstructured":"Belelli D et al (2022) Relating neurosteroid modulation of inhibitory neurotransmission to behaviour. J Neuroendocrinol 34(2):e13045","journal-title":"J Neuroendocrinol"},{"issue":"4","key":"5918_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060863","volume":"8","author":"S Moriguchi","year":"2013","unstructured":"Moriguchi S, Shinoda Y, Yamamoto Y, Sasaki Y, Miyajima K, Tagashira H, Fukunaga K (2013Apr 8) Stimulation of the sigma-1 receptor by DHEA enhances synaptic efficacy and neurogenesis in the hippocampal dentate gyrus of olfactory bulbectomized mice. PLoS ONE 8(4):e60863","journal-title":"PLoS ONE"},{"issue":"2","key":"5918_CR33","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/jcbfm.2008.118","volume":"29","author":"Z Li","year":"2009","unstructured":"Li Z et al (2009) DHEA-neuroprotection and -neurotoxicity after transient cerebral ischemia in rats. J Cereb Blood Flow Metab 29(2):287\u2013296","journal-title":"J Cereb Blood Flow Metab"},{"key":"5918_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24010507","author":"E Szczurowska","year":"2022","unstructured":"Szczurowska E et al (2022) Modulation of muscarinic signalling in the Central Nervous System by steroid hormones and neurosteroids. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24010507","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5918_CR35","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00441-020-03376-6","volume":"383","author":"R Tirindelli","year":"2021","unstructured":"Tirindelli R (2021) Coding of pheromones by vomeronasal receptors. Cell Tissue Res 383(1):367\u2013386","journal-title":"Cell Tissue Res"},{"key":"5918_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/ph16040520","author":"M Stefaniak","year":"2023","unstructured":"Stefaniak M et al (2023) Progesterone and its metabolites play a beneficial role in affect regulation in the female brain. Pharmaceuticals (Basel). https:\/\/doi.org\/10.3390\/ph16040520","journal-title":"Pharmaceuticals (Basel)"},{"key":"5918_CR37","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/B978-0-12-813814-4.00004-3","volume-title":"Hormonal Signaling in Biology and Medicine","author":"DS Reddy","year":"2020","unstructured":"Reddy DS, Bakshi K (2020) Neurosteroids: biosynthesis, molecular mechanisms, and neurophysiological functions in the human brain. Hormonal Signaling in Biology and Medicine. Elsevier, pp 69\u201382"},{"key":"5918_CR38","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.neulet.2017.05.034","volume":"653","author":"J Guo","year":"2017","unstructured":"Guo J et al (2017) Butylated hydroxyanisole alters rat 5\u03b1-reductase and 3\u03b1-hydroxysteroid dehydrogenase: implications for influences of neurosteroidogenesis. Neurosci Lett 653:132\u2013138","journal-title":"Neurosci Lett"},{"issue":"2","key":"5918_CR39","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1210\/endo.140.2.6528","volume":"140","author":"IH Zwain","year":"1999","unstructured":"Zwain IH, Yen SS (1999) Dehydroepiandrosterone: biosynthesis and metabolism in the brain. Endocrinology 140(2):880\u2013887","journal-title":"Endocrinology"},{"issue":"11","key":"5918_CR40","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1046\/j.1432-1327.2000.01349.x","volume":"267","author":"P Soucy","year":"2000","unstructured":"Soucy P, Luu-The V (2000) Conversion of pregnenolone to DHEA by human 17alpha-hydroxylase\/17, 20-lyase (P450c17). Evidence that DHEA is produced from the released intermediate, 17alpha-hydroxypregnenolone. Eur J Biochem 267(11):3243\u20137","journal-title":"Eur J Biochem"},{"issue":"2\u20133","key":"5918_CR41","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0960-0760(00)00163-1","volume":"75","author":"C Cascio","year":"2000","unstructured":"Cascio C et al (2000) Pathways of dehydroepiandrosterone formation in rat brain glia. J Steroid Biochem Mol Biol 75(2\u20133):177\u2013186","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"7","key":"5918_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102110","volume":"298","author":"YC Lin","year":"2022","unstructured":"Lin YC et al (2022) The neurosteroid pregnenolone is synthesized by a mitochondrial P450 enzyme other than CYP11A1 in human glial cells. J Biol Chem 298(7):102110","journal-title":"J Biol Chem"},{"key":"5918_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2023.105356","volume":"153","author":"DR Seib","year":"2023","unstructured":"Seib DR et al (2023) Neurosteroids and the mesocorticolimbic system. Neurosci Biobehav Rev 153:105356","journal-title":"Neurosci Biobehav Rev"},{"issue":"3","key":"5918_CR44","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.biopsych.2023.01.022","volume":"94","author":"NL Walton","year":"2023","unstructured":"Walton NL et al (2023) Impaired endogenous neurosteroid signaling contributes to behavioral deficits associated with chronic stress. Biol Psychiatry 94(3):249\u2013261","journal-title":"Biol Psychiatry"},{"key":"5918_CR45","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.psyneuen.2018.05.016","volume":"95","author":"L Guo","year":"2018","unstructured":"Guo L et al (2018) Sex hormones affect acute and chronic stress responses in sexually dimorphic patterns: consequences for depression models. Psychoneuroendocrinology 95:34\u201342","journal-title":"Psychoneuroendocrinology"},{"key":"5918_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2024.108087","volume":"188","author":"T Fidecicchi","year":"2024","unstructured":"Fidecicchi T et al (2024) Neuroendocrine mechanisms of mood disorders during menopause transition: a narrative review and future perspectives. Maturitas 188:108087","journal-title":"Maturitas"},{"key":"5918_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232113075","author":"E Szczurowska","year":"2022","unstructured":"Szczurowska E et al (2022) Allosteric modulation of muscarinic receptors by cholesterol, neurosteroids and neuroactive steroids. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms232113075","journal-title":"Int J Mol Sci"},{"key":"5918_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.coemr.2021.100310","volume":"22","author":"YC Lin","year":"2022","unstructured":"Lin YC et al (2022) Function, regulation, and pharmacological effects of pregnenolone in the central nervous system. Current Opinion in Endocrine and Metabolic Research 22:100310","journal-title":"Curr Opin Endocrine Metab Res"},{"key":"5918_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.105035","author":"YC Lin","year":"2023","unstructured":"Lin YC et al (2023) Mitochondrial cytochrome P450 1B1 is involved in pregnenolone synthesis in human brain cells. J Biol Chem. https:\/\/doi.org\/10.1016\/j.jbc.2023.105035","journal-title":"J Biol Chem"},{"key":"5918_CR50","doi-asserted-by":"crossref","unstructured":"Borowicz-Reutt K (2017) Neurosteroids and their neuroprotective actions. In Health Science International Conference (HSIC 2017). Atlantis Press, pp 216\u2013226","DOI":"10.2991\/hsic-17.2017.35"},{"key":"5918_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.820241","volume":"13","author":"P Sharma","year":"2022","unstructured":"Sharma P et al (2022) Sex specific transcriptional regulation of gonadal steroidogenesis in teleost fishes. Front Endocrinol 13:820241","journal-title":"Front Endocrinol"},{"issue":"6","key":"5918_CR52","doi-asserted-by":"publisher","first-page":"166757","DOI":"10.1016\/j.bbadis.2023.166757","volume":"1869","author":"PR Manna","year":"2023","unstructured":"Manna PR, Bose C, Reddy PH (2023) Downregulation of StAR driven neurosteroid biosynthesis as a distinctive feature in the brains of Alzheimer\u2019s disease patients. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1869(6):166757","journal-title":"Biochimica et Biophysica Acta (BBA)-Mol Basis Dis"},{"issue":"1","key":"5918_CR53","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1159\/000525677","volume":"113","author":"TB Bassani","year":"2023","unstructured":"Bassani TB et al (2023) Progestogen-mediated neuroprotection in central nervous system disorders. Neuroendocrinology 113(1):14\u201335","journal-title":"Neuroendocrinology"},{"key":"5918_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.552805","volume":"11","author":"CA Frye","year":"2020","unstructured":"Frye CA, Lembo VF, Walf AA (2020) Progesterone\u2019s effects on cognitive performance of male mice are independent of progestin receptors but relate to increases in GABA(A) activity in the hippocampus and cortex. Front Endocrinol (Lausanne) 11:552805","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"11","key":"5918_CR55","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.3244","volume":"13","author":"L Amirkhosravi","year":"2023","unstructured":"Amirkhosravi L et al (2023) Evaluating the neuroprotective effects of progesterone receptors on experimental traumatic brain injury: the PI3K\/Akt pathway. Brain Behav 13(11):e3244","journal-title":"Brain Behav"},{"key":"5918_CR56","doi-asserted-by":"publisher","first-page":"1286066","DOI":"10.3389\/fendo.2024.1286066","volume":"15","author":"M Singh","year":"2024","unstructured":"Singh M et al (2024) Brain-derived neuerotrophic factor and related mechanisms that mediate and influence progesterone-induced neuroprotection. Front Endocrinol (Lausanne) 15:1286066","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5918_CR57","doi-asserted-by":"crossref","unstructured":"Jure I, De Nicola AF, Labombarda F (2019) Progesterone effects on oligodendrocyte differentiation in injured spinal cord. Brain Res 1708:36\u201346","DOI":"10.1016\/j.brainres.2018.12.005"},{"key":"5918_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/ph18070945","author":"TA Fedotcheva","year":"2025","unstructured":"Fedotcheva TA, Shimanovsky NL (2025) Neurosteroids Progesterone and Dehydroepiandrosterone: molecular mechanisms of action in neuroprotection and neuroinflammation. Pharmaceuticals (Basel). https:\/\/doi.org\/10.3390\/ph18070945","journal-title":"Pharmaceuticals (Basel)"},{"key":"5918_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21155271","author":"R Guennoun","year":"2020","unstructured":"Guennoun R (2020) Progesterone in the brain: hormone, neurosteroid and neuroprotectant. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21155271","journal-title":"Int J Mol Sci"},{"issue":"2","key":"5918_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.62134\/ajbms\/v2.i2.khatamuni.1","volume":"1","author":"A Tishehyar","year":"2024","unstructured":"Tishehyar A et al (2024) The apoptotic effects of progesterone and testosterone on colon cancer (SW480) cells. Afghanistan Journal of Basic Medical Science 1(2):1\u201312","journal-title":"Afghanistan J Basic Med Sci"},{"issue":"1","key":"5918_CR61","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12258","volume":"8","author":"AC Raikes","year":"2022","unstructured":"Raikes AC et al (2022) Exploratory imaging outcomes of a phase 1b\/2a clinical trial of allopregnanolone as a regenerative therapeutic for Alzheimer\u2019s disease: structural effects and functional connectivity outcomes. Alzheimer\u2019s & Dementia: Translational Research & Clinical Interventions 8(1):e12258","journal-title":"Alzheimer Dementia: Transl Res Clin Interv"},{"key":"5918_CR62","unstructured":"Khodadadi H, Jonaidi H, Esmaeili-Mahani S, Pourmashayekhi M, Jonaidi P (2025) Antioxidant and anti-apoptotic properties of allopregnanolone in protecting dopaminergic neurons from 6-OHDA-induced injury. Vet Comp Biomed Res\u00a02(2):50\u201359"},{"issue":"9","key":"5918_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107545","volume":"26","author":"P Lorenzon","year":"2023","unstructured":"Lorenzon P et al (2023) In vivo spontaneous activity and coital-evoked inhibition of mouse accessory olfactory bulb output neurons. iScience 26(9):107545","journal-title":"iScience"},{"issue":"4","key":"5918_CR64","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/nrendo.2013.31","volume":"9","author":"RD Brinton","year":"2013","unstructured":"Brinton RD (2013) Neurosteroids as regenerative agents in the brain: therapeutic implications. Nat Rev Endocrinol 9(4):241\u2013250","journal-title":"Nat Rev Endocrinol"},{"key":"5918_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2025.102684","volume":"105","author":"HM Al-Kuraishy","year":"2025","unstructured":"Al-Kuraishy HM et al (2025) Beyond amyloid plaque, targeting \u03b1-synuclein in Alzheimer disease: the battle continues. Ageing Res Rev 105:102684","journal-title":"Ageing Res Rev"},{"key":"5918_CR66","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqac183","author":"N Fernandez","year":"2022","unstructured":"Fernandez N et al (2022) Aging is associated with lower neuroactive steroids and worsened outcomes following cerebral ischemia in male mice. Endocrinology. https:\/\/doi.org\/10.1210\/endocr\/bqac183","journal-title":"Endocrinology"},{"issue":"145","key":"5918_CR67","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.jsbmb.2014.03.008","volume":"1","author":"L St\u00e1rka","year":"2015","unstructured":"St\u00e1rka L, Du\u0161kov\u00e1 M, Hill M (2015Jan) Dehydroepiandrosterone: a neuroactive steroid. J Steroid Biochem Mol Biol 1(145):254\u2013260","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"11","key":"5918_CR68","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1016\/j.neurobiolaging.2009.12.014","volume":"32","author":"S Luchetti","year":"2011","unstructured":"Luchetti S et al (2011) Neurosteroid biosynthetic pathways changes in prefrontal cortex in Alzheimer\u2019s disease. Neurobiol Aging 32(11):1964\u201376","journal-title":"Neurobiol Aging"},{"issue":"2","key":"5918_CR69","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s12017-018-8493-y","volume":"20","author":"M Hasanpour","year":"2018","unstructured":"Hasanpour M et al (2018) The dynamics of neurosteroids and sex-related hormones in the pathogenesis of Alzheimer\u2019s disease. Neuromolecular Med 20(2):215\u2013224","journal-title":"Neuromolecular Med"},{"issue":"11","key":"5918_CR70","doi-asserted-by":"publisher","first-page":"5199","DOI":"10.1210\/jc.2003-030646","volume":"88","author":"SB Kim","year":"2003","unstructured":"Kim SB et al (2003) Neurosteroids: cerebrospinal fluid levels for Alzheimer\u2019s disease and vascular dementia diagnostics. J Clin Endocrinol Metab 88(11):5199\u20135206","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"5918_CR71","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1080\/00498254.2018.1440656","volume":"49","author":"Y Asai","year":"2019","unstructured":"Asai Y et al (2019) Expression and activities of sulfotransferase in rat brain. Xenobiotica 49(3):270\u2013275","journal-title":"Xenobiotica"},{"key":"5918_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2019.110535","volume":"496","author":"FA Alherz","year":"2019","unstructured":"Alherz FA et al (2019) Effect of SULT2B1 genetic polymorphisms on the sulfation of dehydroepiandrosterone and pregnenolone by SULT2B1b allozymes. Mol Cell Endocrinol 496:110535","journal-title":"Mol Cell Endocrinol"},{"issue":"8","key":"5918_CR73","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.tem.2008.07.004","volume":"19","author":"I Charalampopoulos","year":"2008","unstructured":"Charalampopoulos I et al (2008) Neurosteroids as modulators of neurogenesis and neuronal survival. Trends Endocrinol Metab 19(8):300\u2013307","journal-title":"Trends Endocrinol Metab"},{"issue":"17","key":"5918_CR74","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.1007\/s00213-014-3435-3","volume":"231","author":"F El Bitar","year":"2014","unstructured":"El Bitar F et al (2014) Neuroprotection by the synthetic neurosteroid enantiomers ent-PREGS and ent-DHEAS against A\u03b2\u2082\u2085\u208b\u2083\u2085 peptide-induced toxicity in vitro and in vivo in mice. Psychopharmacology 231(17):3293\u20133312","journal-title":"Psychopharmacology"},{"issue":"4-5","key":"5918_CR75","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.neuropharm.2010.02.009","volume":"59","author":"L Li","year":"2010","unstructured":"Li L et al (2010) DHEA prevents A\u03b225-35-impaired survival of newborn neurons in the dentate gyrus through a modulation of PI3K-Akt-mTOR signaling. Neuropharmacology 59(4\u20135):323\u201333","journal-title":"Neuropharmacology"},{"issue":"1","key":"5918_CR76","first-page":"209","volume":"4","author":"M Kato-Negishi","year":"2008","unstructured":"Kato-Negishi M, Kawahara M (2008) Neurosteroids block the increase in intracellular calcium level induced by Alzheimer\u2019s \u03b2-amyloid protein in long-term cultured rat hippocampal neurons. Neuropsychiatr Dis Treat 4(1):209\u2013218","journal-title":"Neuropsychiatr Dis Treat"},{"key":"5918_CR77","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.brainres.2018.02.023","volume":"1686","author":"AL Mendell","year":"2018","unstructured":"Mendell AL et al (2018) Neurosteroid metabolites of testosterone and progesterone differentially inhibit ERK phosphorylation induced by amyloid \u03b2 in SH-SY5Y cells and primary cortical neurons. Brain Res 1686:83\u201393","journal-title":"Brain Res"},{"issue":"8","key":"5918_CR78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024293","volume":"6","author":"S Chen","year":"2011","unstructured":"Chen S et al (2011) Allopregnanolone promotes regeneration and reduces \u03b2-amyloid burden in a preclinical model of Alzheimer\u2019s disease. PLoS One 6(8):e24293","journal-title":"PLoS One"},{"issue":"12","key":"5918_CR79","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.biopsych.2006.06.017","volume":"60","author":"CE Marx","year":"2006","unstructured":"Marx CE et al (2006) The neurosteroid allopregnanolone is reduced in prefrontal cortex in Alzheimer\u2019s disease. Biol Psychiatry 60(12):1287\u20131294","journal-title":"Biol Psychiatry"},{"issue":"4","key":"5918_CR80","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2174\/156720508785132325","volume":"5","author":"G Barry","year":"2008","unstructured":"Barry G, Ross IL (2008) Neurosteroids and sporadic Alzheimer\u2019s diseas. Curr Alzheimer Res 5(4):367\u2013374","journal-title":"Curr Alzheimer Res"},{"issue":"6","key":"5918_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2023.166757","volume":"1869","author":"PR Manna","year":"2023","unstructured":"Manna PR, Bose C, Reddy PH (2023) Downregulation of StAR driven neurosteroid biosynthesis as a distinctive feature in the brains of Alzheimer\u2019s disease patients. Biochim Biophys Acta Mol Basis Dis 1869(6):166757","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"3","key":"5918_CR82","doi-asserted-by":"publisher","first-page":"167667","DOI":"10.1016\/j.bbadis.2025.167667","volume":"1871","author":"PR Manna","year":"2025","unstructured":"Manna PR, Yang S, Reddy PH (2025) Transcriptomic analysis reveals suppression of steroidogenic acute regulatory protein in gender-specific differences in Alzheimer\u2019s disease. Biochim Biophys Acta Mol Basis Dis 1871(3):167667","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"5918_CR83","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25137106","author":"S \u017buli\u0144ska","year":"2024","unstructured":"\u017buli\u0144ska S, Strosznajder AK, Strosznajder JB (2024) Current view on PPAR-\u03b1 and its relation to neurosteroids in Alzheimer\u2019s Disease and other neuropsychiatric disorders: promising targets in a therapeutic strategy. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25137106","journal-title":"Int J Mol Sci"},{"issue":"6","key":"5918_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2023.166738","volume":"1869","author":"PR Manna","year":"2023","unstructured":"Manna PR et al (2023) Protective function of StAR in amyloid-\u03b2 accumulated hippocampal neurotoxicity and neurosteroidogenesis: mechanistic insights into Alzheimer\u2019s disease. Biochimica et Biophysica Acta (BBA) 1869(6):166738","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"4","key":"5918_CR85","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14463","volume":"30","author":"S Davoody","year":"2024","unstructured":"Davoody S et al (2024) mTOR signaling and Alzheimer\u2019s disease: what we know and where we are? CNS Neurosci Ther 30(4):e14463","journal-title":"CNS Neurosci Ther"},{"key":"5918_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2020.113043","volume":"400","author":"M Chen","year":"2021","unstructured":"Chen M et al (2021) AMPK: a bridge between diabetes mellitus and Alzheimer\u2019s disease. Behav Brain Res 400:113043","journal-title":"Behav Brain Res"},{"key":"5918_CR87","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci13020163","author":"A Gliwi\u0144ska","year":"2023","unstructured":"Gliwi\u0144ska A et al (2023) The role of Brain-Derived Neurotrophic Factor (BDNF) in diagnosis and treatment of epilepsy, depression, schizophrenia, anorexia nervosa and Alzheimer\u2019s Disease as highly drug-resistant diseases: a narrative review. Brain Sci. https:\/\/doi.org\/10.3390\/brainsci13020163","journal-title":"Brain Sci"},{"issue":"11","key":"5918_CR88","doi-asserted-by":"publisher","first-page":"4528","DOI":"10.1038\/s41380-023-02242-5","volume":"28","author":"A Litwiniuk","year":"2023","unstructured":"Litwiniuk A et al (2023) The role of glial autophagy in Alzheimer\u2019s disease. Mol Psychiatry 28(11):4528\u20134539","journal-title":"Mol Psychiatry"},{"issue":"Pt 2","key":"5918_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.142933","volume":"309","author":"HM Al-Kuraishy","year":"2025","unstructured":"Al-Kuraishy HM et al (2025) Targeting of AMPK\/MTOR signaling in the management of atherosclerosis: outmost leveraging. Int J Biol Macromol 309(Pt 2):142933","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"5918_CR90","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s10571-025-01554-0","volume":"45","author":"SM Alqahtani","year":"2025","unstructured":"Alqahtani SM et al (2025) Targeting of PP2 A\/GSK3\u03b2\/PTEN axis in Alzheimer disease: the mooting evidence, divine, and devil. Cell Mol Neurobiol 45(1):36","journal-title":"Cell Mol Neurobiol"},{"key":"5918_CR91","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.freeradbiomed.2021.04.025","volume":"169","author":"M Perluigi","year":"2021","unstructured":"Perluigi M et al (2021) mTOR in Alzheimer disease and its earlier stages: links to oxidative damage in the progression of this dementing disorder. Free Radic Biol Med 169:382\u2013396","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"5918_CR92","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.3233\/JAD-161029","volume":"56","author":"HK Lee","year":"2017","unstructured":"Lee HK et al (2017) mTORC2 (Rictor) in Alzheimer\u2019s disease and reversal of amyloid-\u03b2 expression-induced insulin resistance and toxicity in rat primary cortical neurons. J Alzheimers Dis 56(3):1015\u20131036","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"5918_CR93","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1080\/15548627.2020.1731270","volume":"17","author":"M Ishikawa","year":"2021","unstructured":"Ishikawa M et al (2021) The neurosteroid allopregnanolone protects retinal neurons by effects on autophagy and GABRs\/GABA(A) receptors in rat glaucoma models. Autophagy 17(3):743\u2013760","journal-title":"Autophagy"},{"key":"5918_CR94","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3389\/fncel.2014.00203","volume":"8","author":"RW Irwin","year":"2014","unstructured":"Irwin RW, Solinsky CM, Brinton RD (2014) Frontiers in therapeutic development of allopregnanolone for Alzheimer\u2019s disease and other neurological disorders. Front Cell Neurosci 8:203","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"5918_CR95","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s13311-019-00793-6","volume":"17","author":"T Wang","year":"2020","unstructured":"Wang T et al (2020) Allopregnanolone reverses bioenergetic deficits in female triple transgenic Alzheimer\u2019s mouse model. Neurotherapeutics 17(1):178\u2013188","journal-title":"Neurotherapeutics"},{"issue":"2","key":"5918_CR96","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.neuint.2011.11.015","volume":"60","author":"HN Kim","year":"2012","unstructured":"Kim HN, Lee SJ, Koh JY (2012) The neurosteroids, allopregnanolone and progesterone, induce autophagy in cultured astrocytes. Neurochem Int 60(2):125\u2013133","journal-title":"Neurochem Int"},{"key":"5918_CR97","doi-asserted-by":"crossref","unstructured":"Divya et al (2025)\u00a0Ganaxolone reverses the effect of amyloid \u03b2-induced neurotoxicity by regulating the liver X receptor expression in APP transfected SH-SY5Y cells and murine model of Alzheimer\u2019s disease. J Neurochem\u00a0169(2):e70007","DOI":"10.1111\/jnc.70007"},{"issue":"1","key":"5918_CR98","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/dmcn.15766","volume":"66","author":"S Amin","year":"2024","unstructured":"Amin S (2024) Rare epilepsy treatment: what is on the gene-code lottery list? Dev Med Child Neurol 66(1):6\u20137","journal-title":"Dev Med Child Neurol"},{"key":"5918_CR99","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-025-05126-7","author":"GH Alshehri","year":"2025","unstructured":"Alshehri GH et al (2025) The AMPK\/GDF15 axis: a novel target for the neuroprotective effects of metformin in ischemic stroke. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-025-05126-7","journal-title":"Mol Neurobiol"},{"issue":"1","key":"5918_CR100","doi-asserted-by":"publisher","first-page":"66","DOI":"10.2174\/1389203720666190819142746","volume":"21","author":"L Yang","year":"2020","unstructured":"Yang L et al (2020) AMPK: potential therapeutic target for Alzheimer\u2019s disease. Curr Protein Pept Sci 21(1):66\u201377","journal-title":"Curr Protein Pept Sci"},{"issue":"3","key":"5918_CR101","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1007\/s12020-024-03755-x","volume":"85","author":"A Rasic-Markovic","year":"2024","unstructured":"Rasic-Markovic A et al (2024) Neuroactive steroids in the neuroendocrine control of food intake, metabolism, and reproduction. Endocrine 85(3):1050\u20131057","journal-title":"Endocrine"},{"issue":"1","key":"5918_CR102","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s11033-025-11238-z","volume":"53","author":"Z Al-Qahtani","year":"2025","unstructured":"Al-Qahtani Z et al (2025) Molecular mechanisms of neurosteroids in temporal lobe epilepsy: current insights and therapeutic perspectives. Mol Biol Rep 53(1):124","journal-title":"Mol Biol Rep"},{"key":"5918_CR103","doi-asserted-by":"publisher","DOI":"10.3390\/biom14091190","author":"E Conte","year":"2024","unstructured":"Conte E et al (2024) Therapeutic approaches to tuberous sclerosis complex: from available therapies to promising drug targets. Biomolecules. https:\/\/doi.org\/10.3390\/biom14091190","journal-title":"Biomolecules"},{"key":"5918_CR104","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23126827","author":"KF Azman","year":"2022","unstructured":"Azman KF, Zakaria R (2022) Recent advances on the role of brain-derived neurotrophic factor (BDNF) in neurodegenerative diseases. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23126827","journal-title":"Int J Mol Sci"},{"issue":"12","key":"5918_CR105","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70167","volume":"30","author":"HM Al-Kuraishy","year":"2024","unstructured":"Al-Kuraishy HM et al (2024) The compelling role of brain-derived neurotrophic factor signaling in multiple sclerosis: role of BDNF activators. CNS Neurosci Ther 30(12):e70167","journal-title":"CNS Neurosci Ther"},{"issue":"10","key":"5918_CR106","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18368","volume":"28","author":"NH Ali","year":"2024","unstructured":"Ali NH et al (2024) BDNF\/TrkB activators in Parkinson\u2019s disease: a new therapeutic strategy. J Cell Mol Med 28(10):e18368","journal-title":"J Cell Mol Med"},{"issue":"1","key":"5918_CR107","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s12017-025-08857-x","volume":"27","author":"SM Alqahtani","year":"2025","unstructured":"Alqahtani SM et al (2025) Unlocking Alzheimer\u2019s disease: the role of BDNF signaling in neuropathology and treatment. Neuromol Med 27(1):36","journal-title":"Neuromol Med"},{"key":"5918_CR108","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2025.111338","volume":"226","author":"H Alnoaman","year":"2025","unstructured":"Alnoaman H et al (2025) Dysregulation of proBDNF\/p75(NTR) and BDNF\/TrkB signaling in acute ischemic stroke: different sides of the same coins. Brain Res Bull 226:111338","journal-title":"Brain Res Bull"},{"issue":"5","key":"5918_CR109","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1007\/s12035-023-03727-8","volume":"61","author":"NH Ali","year":"2024","unstructured":"Ali NH et al (2024) The molecular pathway of p75 neurotrophin receptor (p75NTR) in Parkinson\u2019s disease: the way of new inroads. Mol Neurobiol 61(5):2469\u20132480","journal-title":"Mol Neurobiol"},{"issue":"3","key":"5918_CR110","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3233\/JAD-215193","volume":"85","author":"D Cutuli","year":"2022","unstructured":"Cutuli D et al (2022) Environmental enrichment effects on the brain-derived neurotrophic factor expression in healthy condition, Alzheimer\u2019s Disease, and other neurodegenerative disorders. J Alzheimers Dis 85(3):975\u2013992","journal-title":"J Alzheimers Dis"},{"key":"5918_CR111","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22041758","author":"FB Almeida","year":"2021","unstructured":"Almeida FB, Barros HMT, Pinna G (2021) Neurosteroids and neurotrophic factors: what is their promise as biomarkers for major depression and PTSD? Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22041758","journal-title":"Int J Mol Sci"},{"key":"5918_CR112","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fendo.2011.00073","volume":"2","author":"MS Nin","year":"2011","unstructured":"Nin MS et al (2011) Neurosteroids reduce social isolation-induced behavioral deficits: a proposed link with neurosteroid-mediated upregulation of BDNF expression. Front Endocrinol (Lausanne) 2:73","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5918_CR113","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.neuroscience.2025.05.022","volume":"577","author":"K Nagpurkar","year":"2025","unstructured":"Nagpurkar K et al (2025) Neurosteroids as emerging therapeutics for treatment-resistant depression: mechanisms and clinical potential. Neuroscience 577:300\u2013314","journal-title":"Neuroscience"},{"issue":"7","key":"5918_CR114","doi-asserted-by":"publisher","DOI":"10.3390\/ph18070945","volume":"18","author":"TA Fedotcheva","year":"2025","unstructured":"Fedotcheva TA, Shimanovsky NL (2025) Neurosteroids Progesterone and Dehydroepiandrosterone: molecular mechanisms of action in neuroprotection and neuroinflammation. Pharmaceuticals Basel 18(7):945","journal-title":"Pharmaceuticals Basel"},{"issue":"4","key":"5918_CR115","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1007\/s13311-020-00874-x","volume":"17","author":"S Chen","year":"2020","unstructured":"Chen S et al (2020) Allopregnanolone promotes neuronal and oligodendrocyte differentiation in vitro and in vivo: therapeutic implication for Alzheimer\u2019s disease. Neurotherapeutics 17(4):1813\u20131824","journal-title":"Neurotherapeutics"},{"key":"5918_CR116","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.pneurobio.2013.08.004","volume":"113","author":"RW Irwin","year":"2014","unstructured":"Irwin RW, Brinton RD (2014) Allopregnanolone as regenerative therapeutic for Alzheimer\u2019s disease: translational development and clinical promise. Prog Neurobiol 113:40\u201355","journal-title":"Prog Neurobiol"},{"key":"5918_CR117","doi-asserted-by":"publisher","first-page":"105558","DOI":"10.1016\/j.neubiorev.2024.105558","volume":"158","author":"AL Morrow","year":"2024","unstructured":"Morrow AL, Boero G, Balan I (2024) Emerging evidence for endogenous neurosteroid modulation of pro-inflammatory and anti-inflammatory pathways that impact neuropsychiatric disease. Neurosci Biobehav Rev 158:105558","journal-title":"Neurosci Biobehav Rev"},{"issue":"5","key":"5918_CR118","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.14336\/AD.2021.0122","volume":"12","author":"C Scassellati","year":"2021","unstructured":"Scassellati C et al (2021) Promising intervention approaches to potentially resolve neuroinflammation and steroid hormones alterations in Alzheimer\u2019s disease and its neuropsychiatric symptoms. Aging Dis 12(5):1337\u20131357","journal-title":"Aging Dis"},{"key":"5918_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.yfrne.2019.100788","volume":"55","author":"C Yilmaz","year":"2019","unstructured":"Yilmaz C et al (2019) Neurosteroids as regulators of neuroinflammation. Front Neuroendocrinol 55:100788","journal-title":"Front Neuroendocrinol"},{"key":"5918_CR120","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.psyneuen.2017.05.022","volume":"83","author":"P Liere","year":"2017","unstructured":"Liere P et al (2017) Differential effects of the 18-kDa translocator protein (TSPO) ligand etifoxine on steroidogenesis in rat brain, plasma and steroidogenic glands: pharmacodynamic studies. Psychoneuroendocrinology 83:122\u2013134","journal-title":"Psychoneuroendocrinology"},{"issue":"3","key":"5918_CR121","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.bbadis.2015.11.011","volume":"1862","author":"B Janssen","year":"2016","unstructured":"Janssen B et al (2016) Imaging of neuroinflammation in Alzheimer\u2019s disease, multiple sclerosis and stroke: recent developments in positron emission tomography. Biochim Biophys Acta 1862(3):425\u2013441","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"5918_CR122","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1042\/BST20150028","volume":"43","author":"E Da Pozzo","year":"2015","unstructured":"Da Pozzo E et al (2015) Targeting the 18-kDa translocator protein: recent perspectives for neuroprotection. Biochem Soc Trans 43(4):559\u2013565","journal-title":"Biochem Soc Trans"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05918-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-05918-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05918-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T04:16:17Z","timestamp":1779682577000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-05918-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":122,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5918"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-05918-5","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"16 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial"}}],"article-number":"648"}}